Chris Wealth Management

Search This Blog

Suven Life Sciences says positive topline results from a Phase-2 study evaluating samelisant excessive daytime sleepiness

Posted by Able on October 30, 2023

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Plans to approach USFDA in Q1 2024 for an end-of- phase-2 meeting to discuss study results

Plans to seek USFDA's guidance for pivotal phase-3 study

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Comments

Stock Market LIVE Updates: Hong Kong stocks notch 9-day winning streak in longest rally since 2018

Hong Kong stocks extended their rally on Friday, supported by ongoing positive market sentiment fueled by China's increased economic stimulus measures. The Hang Seng Index surged by 1.5%, marking its ninth consecutive day of gains, the longest winning streak since January 2018. Hong Kong-listed Chinese tech giants also saw continued gains, closing 2.7% higher.

Big Daddy LIC manages money nearly double the size of Pakistan's economy

After a significant surge in Indian stocks, the total assets under management (AUM) of the state-owned insurance giant LIC have surpassed the Rs 50 lakh crore milestone, nearly doubling the size of neighboring Pakistan's GDP.

NSE cautions investors against entity offering guaranteed returns

The National Stock Exchange (NSE) on Friday cautioned investors against an entity offering guaranteed returns on investment in the stock market. The statement came after the exchange noticed that an authorised person of its registered stock broker was offering guaranteed returns and was collecting commission on such assured returns from investors.

Suven Life Sciences says positive topline results from a Phase-2 study evaluating samelisant excessive daytime sleepiness

Comments

Post a Comment